Ipilimumab approved for metastatic melanoma

American Journal of Health-System Pharmacy

Volumn 68, Issue 9, 2011, Pages 768-

  Traynor, Kate ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IPILIMUMAB;

DERMATITIS; DRUG APPROVAL; DRUG LABELING; ENDOCRINE DISEASE; ENTEROCOLITIS; FOOD AND DRUG ADMINISTRATION; HEPATITIS; HUMAN; MELANOMA; METASTASIS; NEUROPATHY; NONHUMAN; NOTE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RISK ASSESSMENT; TOXIC EPIDERMAL NECROLYSIS;

EID: 79956045361     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/news110025     Document Type: Note

References (0)